Yoga for two: could partner sessions cut hospital visits for cancer patients?
NCT ID NCT04890834
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a partner-based (dyadic) yoga program can improve quality of life and reduce hospital visits for head and neck cancer patients undergoing chemoradiation, as well as their family caregivers. About 415 patient-caregiver pairs are taking part. The yoga sessions are added to standard care, and researchers will track emergency department visits and quality-of-life scores over 6 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- yoga sessions
- What this could lead to
- If it works, this could offer a low-cost way to improve quality of life and reduce emergency visits for head and neck cancer patients and their caregivers.
- What could go wrong
- This is a behavioral intervention study, not a drug trial, so benefits may be modest. Results depend on participants sticking with the yoga program, and the study is still ongoing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
415 people
The number who actually took part.
- Started
-
Jan 2021
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * PATIENTS: Diagnosed with a primary HNC and going to receive at least 5 weeks (25 fractions) of CRT * PATIENTS: Eastern Cooperative Oncology Group (ECOG) performance status of =\< 2 * PATIENTS: Having a family caregiver (e.g., spouse/partner, sibling, adult child) willing to participate * PATIENTS AND CAREGIVERS: Must be at least 18 years old * PATIENTS AND CAREGIVERS: Able to read and speak English * PATIENTS AND CAREGIVERS: Able to provide informed consent Exclusion Criteria: * PATIENTS AND CAREGIVERS: Who have regularly (self-defined) participated in a yoga program in the year prior to diagnosis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Head and neck carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can new tracers make many cancers light up on scans?
- New PET tracer could spot cancers that standard scans overlook
- Can a simple supplement tame inflammation before cancer surgery?
- FLASH therapy: a flash of hope for head and neck cancer retreatment?
- Can MRI measurements be trusted for head and neck cancer?
- Can a simple fluoride treatment save teeth after cancer radiation?